FPR1 and breast cancer: To prove this hypothesis, we first analyzed RNA microarray data from the METABRIC human breast cancer cohort (online supplemental figure S1A).16 Here, we found a significant positive correlation between the RNA expression levels of formyl peptide receptor 1 (FPR1), an established marker gene of neutrophils, and of CXCR4, whose gene product increases during neutrophil aging on the surface of these immune cells,10 with higher tumor stages.